Published June 16, 2022
| Version v1
Dataset
Open
Dolutegravir in Real Life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho
Authors/Creators
- 1. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (2) Molecular Virology Group, Department of Biomedicine, Basel, Switzerland (3) University of Basel, Basel, Switzerland
- 2. (4) SolidarMed, Partnerships for Health, Maseru, Lesotho
- 3. SolidarMed, Partnerships for Health, Maseru, Lesotho
- 4. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland
- 5. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland (5) University Hospital Basel, Basel, Switzerland
- 6. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland (6) University of Maryland, College Park, MD, USA
- 7. (2) Molecular Virology Group, Department of Biomedicine, Basel, Switzerland (3) University of Basel, Basel, Switzerland
- 8. (1) Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland (5) University Hospital Basel, Basel, Switzerland (§) Corresponding author
Description
Pseudonymized dataset for the accepted manuscript "Dolutegravir in Real Life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho"
Files
Files
(1.5 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:6b70d718fe8921e62449de8aa10ba414
|
1.5 MB | Download |